BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 2434024)

  • 1. Inhibition of replication and cytopathic effect of human T cell lymphotropic virus type III/lymphadenopathy-associated virus by 3'-azido-3'-deoxythymidine in vitro.
    Nakashima H; Matsui T; Harada S; Kobayashi N; Matsuda A; Ueda T; Yamamoto N
    Antimicrob Agents Chemother; 1986 Dec; 30(6):933-7. PubMed ID: 2434024
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phosphorylation of 3'-azido-3'-deoxythymidine and selective interaction of the 5'-triphosphate with human immunodeficiency virus reverse transcriptase.
    Furman PA; Fyfe JA; St Clair MH; Weinhold K; Rideout JL; Freeman GA; Lehrman SN; Bolognesi DP; Broder S; Mitsuya H
    Proc Natl Acad Sci U S A; 1986 Nov; 83(21):8333-7. PubMed ID: 2430286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of 3'-azido-2',3'-dideoxythymidine (AZT) and neutralizing antibody on human immunodeficiency virus (HIV)-induced cytopathic effects: implication of giant cell formation for the spread of virus in vivo.
    Nakashima H; Tochikura T; Kobayashi N; Matsuda A; Ueda T; Yamamoto N
    Virology; 1987 Jul; 159(1):169-73. PubMed ID: 3111083
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 3'-Azido-3'-deoxythymidine (BW A509U): an antiviral agent that inhibits the infectivity and cytopathic effect of human T-lymphotropic virus type III/lymphadenopathy-associated virus in vitro.
    Mitsuya H; Weinhold KJ; Furman PA; St Clair MH; Lehrman SN; Gallo RC; Bolognesi D; Barry DW; Broder S
    Proc Natl Acad Sci U S A; 1985 Oct; 82(20):7096-100. PubMed ID: 2413459
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibitory effect of 2',3'-didehydro-2',3'-dideoxynucleosides on infectivity, cytopathic effects, and replication of human immunodeficiency virus.
    Hamamoto Y; Nakashima H; Matsui T; Matsuda A; Ueda T; Yamamoto N
    Antimicrob Agents Chemother; 1987 Jun; 31(6):907-10. PubMed ID: 3039911
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibitory effect of glycyrrhizin on the in vitro infectivity and cytopathic activity of the human immunodeficiency virus [HIV (HTLV-III/LAV)].
    Ito M; Nakashima H; Baba M; Pauwels R; De Clercq E; Shigeta S; Yamamoto N
    Antiviral Res; 1987 Mar; 7(3):127-37. PubMed ID: 3475037
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro selection of human immunodeficiency virus type 1 resistant to 3'-azido-3'-deoxythymidine.
    Dianzani F; Antonelli G; Turriziani O; Dong G; Capobianchi MR; Riva E
    Antiviral Res; 1992 May; 18(1):39-52. PubMed ID: 1384427
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 3'-Azido-3'-deoxythymidine prevents induction of murine acquired immunodeficiency syndrome in C57BL/10 mice infected with LP-BM5 murine leukemia viruses, a possible animal model for antiretroviral drug screening.
    Ohnota H; Okada Y; Ushijima H; Kitamura T; Komuro K; Mizuochi T
    Antimicrob Agents Chemother; 1990 Apr; 34(4):605-9. PubMed ID: 1693056
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Resumption of virus production after human immunodeficiency virus infection of T lymphocytes in the presence of azidothymidine.
    Smith MS; Brian EL; Pagano JS
    J Virol; 1987 Dec; 61(12):3769-73. PubMed ID: 2446006
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sensitive and rapid assay on MT-4 cells for detection of antiviral compounds against the AIDS virus.
    Pauwels R; De Clercq E; Desmyter J; Balzarini J; Goubau P; Herdewijn P; Vanderhaeghe H; Vandeputte M
    J Virol Methods; 1987 Jun; 16(3):171-85. PubMed ID: 2821048
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suppression of human immunodeficiency virus replication by 3'-azido-3'-deoxythymidine in various human hematopoietic cell lines in vitro: augmentation of the effect by lentinan.
    Tochikura TS; Nakashima H; Kaneko Y; Kobayashi N; Yamamoto N
    Jpn J Cancer Res; 1987 Jun; 78(6):583-9. PubMed ID: 3112074
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor promoter, TPA, enhances replication of HTLV-III/LAV.
    Harada S; Koyanagi Y; Nakashima H; Kobayashi N; Yamamoto N
    Virology; 1986 Oct; 154(2):249-58. PubMed ID: 3639669
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synergistic activity of granulocyte-macrophage colony-stimulating factor and 3'-azido-3'-deoxythymidine against human immunodeficiency virus in vitro.
    Hammer SM; Gillis JM
    Antimicrob Agents Chemother; 1987 Jul; 31(7):1046-50. PubMed ID: 2444155
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Substances affecting the infection and replication of human immunodeficiency virus (HIV).
    Yamamoto N; Harada S; Nakashima H
    AIDS Res; 1986 Dec; 2 Suppl 1():S183-9. PubMed ID: 3030346
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Infection of human T-lymphotropic virus type-I (HTLV-I)-bearing MT-4 cells with HTLV-III (AIDS virus): chronological studies of early events.
    Harada S; Koyanagi Y; Yamamoto N
    Virology; 1985 Oct; 146(2):272-81. PubMed ID: 2413616
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human immunodeficiency virus inhibition is prolonged by 3'-azido-3'-deoxythymidine alternating with 2',3'-dideoxycytidine compared with 3'-azido-3'-deoxythymidine alone.
    Spector SA; Ripley D; Hsia K
    Antimicrob Agents Chemother; 1989 Jun; 33(6):920-3. PubMed ID: 2548440
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Infection of HTLV-III/LAV in HTLV-I-carrying cells MT-2 and MT-4 and application in a plaque assay.
    Harada S; Koyanagi Y; Yamamoto N
    Science; 1985 Aug; 229(4713):563-6. PubMed ID: 2992081
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of replication of the etiologic agent of acquired immune deficiency syndrome (human T-lymphotropic retrovirus/lymphadenopathy-associated virus) by avarol and avarone.
    Sarin PS; Sun D; Thornton A; Müller WE
    J Natl Cancer Inst; 1987 Apr; 78(4):663-6. PubMed ID: 2435942
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synergistic inhibition of human immunodeficiency virus type 1 replication in vitro by two-drug and three-drug combinations of 3'-azido-3'-deoxythymidine, phosphonoformate, and 2',3'-dideoxythymidine.
    Kong XB; Zhu QY; Ruprecht RM; Watanabe KA; Zeidler JM; Gold JW; Polsky B; Armstrong D; Chou TC
    Antimicrob Agents Chemother; 1991 Oct; 35(10):2003-11. PubMed ID: 1722077
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiviral effects of 3'-azido-3'-deoxythymidine, 2',3'-dideoxycytidine, and 2',3'-dideoxyadenosine against simian acquired immunodeficiency syndrome-associated type D retrovirus in vitro.
    Tsai CC; Follis KE; Benveniste RE
    AIDS Res Hum Retroviruses; 1988 Oct; 4(5):359-68. PubMed ID: 2461724
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.